OFFICIAL PUBLICATION OF

by its subsidiary APPco

New therapies for hep C listed

AJP Staff 18/04/2016

New therapies have been PBS listed for the treatment of genotype 1 chronic hepatitis C virus. AbbVie Australia today announced that Viekira Pak (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Viekira Pak-RBV (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets with ribavirin) will be listed on the PBS from 1st May 2016. The two therapies are approved for use

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

New therapies for hep C listed

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.